Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dermata Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1
Net income  -10.5-3.2-4.7
Depreciation and amortization   0.00.0
Stock-based compensation  3.5  
Change in working capital   [+]1.9-0.30.2
Other operating activities  -0.6-0.50.6
Cash from operations  -5.7-4.0-3.9
   
Capital expenditures  0.00.00.0
Cash from investing  0.00.00.0
   
Other cash from financing  16.02.64.7
Cash from financing  16.02.64.7
   
Free cash flow  -5.7-4.0-3.9
        Per share (diluted)  ($1.32)($2.11)($2.05)
   
Cash paid for interest  0.00.10.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy